Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-27
DOI
10.1038/s41598-018-22357-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy
- (2016) Pierre Lovinfosse et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- MAPS: A Quantitative Radiomics Approach for Prostate Cancer Detection
- (2016) Andrew Cameron et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Present and future roles of FDG-PET/CT imaging in the management of lung cancer
- (2016) Kazuhiro Kitajima et al. JAPANESE JOURNAL OF RADIOLOGY
- The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung Cancer
- (2016) W. Grootjans et al. JOURNAL OF NUCLEAR MEDICINE
- Stage III Non–Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors
- (2016) David V. Fried et al. RADIOLOGY
- Early-Stage Non–Small Cell Lung Cancer: Quantitative Imaging Characteristics of18F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis
- (2016) Jia Wu et al. RADIOLOGY
- Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer
- (2016) Yanqi Huang et al. RADIOLOGY
- Radiomics: Images Are More than Pictures, They Are Data
- (2016) Robert J. Gillies et al. RADIOLOGY
- Present and future roles of FDG-PET/CT imaging in the management of lung cancer
- (2016) Kazuhiro Kitajima et al. Japanese Journal of Radiology
- FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non–Small-Cell Lung Cancer
- (2015) Woocheol Kwon et al. Journal of Thoracic Oncology
- Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy
- (2015) Thomas Pyka et al. Radiation Oncology
- Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of18F-FDG Uptake at PET—Association with Treatment Response and Prognosis
- (2015) Gary J. R. Cook et al. RADIOLOGY
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Predictive Factors for Local Control in Primary and Metastatic Lung Tumours after Four to Five Fraction Stereotactic Ablative Body Radiotherapy: A Single Institution's Comprehensive Experience
- (2014) I. Thibault et al. CLINICAL ONCOLOGY
- Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non–Small-Cell Lung Cancer Receiving Radiotherapy: Meta-Analysis
- (2014) Feifei Na et al. Journal of Thoracic Oncology
- Noninvasive Image Texture Analysis Differentiates K-ras Mutation from Pan-Wildtype NSCLC and Is Prognostic
- (2014) Glen J. Weiss et al. PLoS One
- Stereotactic Body Radiation Therapy for Lung Cancer
- (2013) Charles B. Simone et al. CHEST
- Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non-Small Cell Lung Cancer
- (2013) T. Win et al. CLINICAL CANCER RESEARCH
- Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Stage I Non–Small-Cell Lung Cancer
- (2013) Cliff G. Robinson et al. Journal of Thoracic Oncology
- Volume-based Parameters Measured by Using FDG PET/CT in Patients with Stage I NSCLC Treated with Stereotactic Body Radiation Therapy: Prognostic Value
- (2013) Yoko Satoh et al. RADIOLOGY
- Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET
- (2012) F. Tixier et al. JOURNAL OF NUCLEAR MEDICINE
- Are Pretreatment 18F-FDG PET Tumor Textural Features in Non-Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?
- (2012) G. J. R. Cook et al. JOURNAL OF NUCLEAR MEDICINE
- Preliminary Report of Late Recurrences, at 5 Years or More, after Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer
- (2012) Yukinori Matsuo et al. Journal of Thoracic Oncology
- Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
- (2012) Joe Y Chang et al. Radiation Oncology
- Non–Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CT
- (2012) Balaji Ganeshan et al. RADIOLOGY
- Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy
- (2011) Yoko Satoh et al. EUROPEAN JOURNAL OF RADIOLOGY
- Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
- (2011) Balaji Ganeshan et al. EUROPEAN RADIOLOGY
- The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT)
- (2011) Atsuya Takeda et al. RADIOTHERAPY AND ONCOLOGY
- Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer
- (2011) Manushka Vaidya et al. RADIOTHERAPY AND ONCOLOGY
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
- (2010) Robert Timmerman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)
- (2010) Neal E. Dunlap et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
- (2010) Marianne Paesmans et al. Journal of Thoracic Oncology
- Revisiting the prognostic value of preoperative 18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC)
- (2009) Mohit Agarwal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Advanced-Stage Non–Small-Cell Lung Carcinoma
- (2008) Jenny K. Hoang et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More